Investors

News Release

<< Back
Codexis to Present at Upcoming Conferences in Brazil and New York

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Sep. 13, 2012-- Codexis, Inc. (NASDAQ: CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceuticals, today announced participation at the following upcoming conferences:

World Biofuels Markets Brazil
Date: Tuesday, September 18
Time: 4:20 p.m. BRT
Location: Grand Hyatt Sao Paulo in Sao Paulo, Brazil
Speaker: David Anton, Senior Vice President, Bioindustrials

Credit Suisse 3rd Annual Small & Mid Cap Conference
Date: Thursday, September 20
Time: 8:00 a.m. EDT
Location: New York Palace Hotel in New York, NY
Speaker: John Nicols, President and Chief Executive Officer

About Codexis, Inc.

Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals and pharmaceuticals. Codexis’ product lines include CodeXyme™ cellulase enzymes and CodeXol™ detergent alcohol. Partners and customers include global leaders such as Merck, Pfizer and Teva. For more information, see www.codexis.com.

Source: Codexis, Inc.

Codexis, Inc.
Investors:
Paul Cox, 212-362-1200
ir@codexis.com
Media:
Kelly McAlearney, 415-503-4073
media@codexis.com

Print Page Print Page | E-mail Page E-mail Page |

Share Page

X
| Financial Tear Sheet Tear Sheet

WE ARE BIOCATALYSIS®

We are an industrial biotechnology company providing unique, state-of-the-art enzyme optmization services and biocatalyst products.


BIOCATALYSIS PRODUCTS

Codexis offers complete biocatalysis solutions from “off-the-shelf” enzymes and Screening Kits, to commercial supply of biocatalysts.

CODEXIS

CODEEVOLVER®


Our protein engineering technology enables the rapid development of custom-designed enzymes

CODEXIS

MEDIA CENTER


Visit our Media Center for the latest press information, videos, imagery, and technical papers.

CAREERS AT CODEXIS

Continued success at Codexis depends on the innovation, collaboration and commitment of people who are passionate about what they do


CODEXIS

INVESTOR CENTER


Access to Codexis information for the investment community


built@zoomedia
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue